Z-square

Company Overview

Snapshot

Founded in April 2013 by Asaf Shahmoon and Zeev Zalevsky, Z-square operates with 11–50 employees. The company has raised $10M across one funding round from two investors, with The Chartered Group identified as a lead investor. In March 2020, Z-square was recognized as a Silver Winner of the 2020 Edison Awards for its innovative microendoscope technology.

Business overview

Z-square develops proprietary multifunctional microendoscopes designed for high-quality, minimally invasive imaging using super-slim fibers. Its technology platform integrates elements for comprehensive imaging, treatment, energy and drug delivery, irrigation, and tissue handling. The company's single-use endoscopes aim to eliminate cross-contamination risks associated with reusable devices, thereby improving patient outcomes, reducing healthcare costs, enhancing diagnostic quality, and expanding access to endoscopic-assisted procedures. Z-square operates within the Health Tech & Life Sciences sector, with a focus on Medical Devices, Medical Treatment & Therapeutics, and Diagnostics Devices, serving healthcare providers globally.

Strategic signal

Z-square's recognition as a Silver Winner of the 2020 Edison Awards in March 2020 highlights the company's innovative contributions to medical technology. This award validates the potential of its microendoscope for minimally invasive imaging and treatment, signaling to investors a strong market need for advanced, safer diagnostic and therapeutic tools in healthcare.

Company Intelligence Q&A

When was Z-square founded and by whom?

Z-square was founded in April 2013 by co-founders Asaf Shahmoon and Zeev Zalevsky.

What is Z-square's primary product or technology?

Z-square develops a proprietary multifunctional microendoscope capable of high-quality, minimally invasive imaging within a super-slim fiber, offering elements for imaging, treatment, and various deliveries.

What significant recognition did Z-square receive in 2020?

In March 2020, Z-square was named a Silver Winner of the 2020 Edison Awards for its innovative microendoscope technology.

Which investors participated in Z-square's funding round in February 2019?

In February 2019, Z-square secured funding with The Chartered Group as a lead investor, and also received investment from.

What problem do Z-square's single-use endoscopes address?

Z-square's single-use endoscopes aim to remove the possibility of cross-contamination often associated with poorly sterilized reusable endoscopes, improving patient safety and healthcare efficiency.